🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsHas anyone dealt with glucagon-mediated thermogenesis on retatrutide? Page 2

Has anyone dealt with glucagon-mediated thermogenesis on retatrutide?

DoseLogDan Fri, Feb 13, 2026 at 11:14 PM 7 replies 870 viewsPage 2 of 2
rick_sfbay
Member
289
1,234
Jan 2025
San Francisco, CA
Feb 14, 2026 at 2:04 AM#6

43 lbs in 16 weeks!! That's amazing results. Congratulations! I'm on the waitlist for a GLP-1 prescription and hearing about results like this makes the wait so hard. How did you get into the clinical trial? Is enrollment still open?

Last edited: Feb 14, 2026 at 8:04 AM
18 17mike_mealprep, NicoleRaleigh, james_edin and 15 others
Reply Quote Save Share Report
mona_PHX
Member
189
890
Dec 2024
Phoenix, AZ
Feb 14, 2026 at 2:21 AM#7

Thanks! I found the trial through ClinicalTrials.gov and was screened at a local research site. I believe most TRIUMPH trial sites have finished enrollment, but you can check ClinicalTrials.gov for any remaining open sites — search for "retatrutide" and filter by recruiting status.

The enrollment process was extensive: multiple screening visits, blood work, ECG, medical history review, and informed consent. It's not as simple as walking in and getting the drug. And of course, there's always the possibility of being randomized to placebo (though I was fortunate to be on active drug).

36 21JenPlateau, SallyK_inj, CryptoCarl and 33 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Feb 14, 2026 at 2:38 AM#8

For context on the rate of weight loss, here's how the OP's trajectory compares to mean trial data:

  • OP at 16 weeks: 16.1%
  • Phase 2 mean at 24 weeks (12mg): ~17% (estimated from published curves)
  • Phase 2 mean at 48 weeks (12mg): 24.2%

The OP is trending above the Phase 2 mean curve, which is not unusual — individual responses vary and the OP's BMI at baseline was relatively high, which often correlates with faster absolute (but not always percentage) weight loss.

The weight loss curve typically follows a logarithmic pattern: steep early, gradually flattening. I'd expect the OP's rate to slow over the next 8-16 weeks as the body adapts and the caloric deficit narrows (lower body weight = lower TDEE).

48 18mark_tokyo, hans_munich, jason_sac26 and 45 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 14, 2026 at 2:55 AM#9

Appreciate this thread and the responsible way it's being discussed. Reminder that clinical trial participants are bound by their informed consent agreements — please be mindful of what specific details you share publicly, as some trial protocols restrict participant disclosure.

For anyone considering clinical trial participation: it's a legitimate and valuable way to access investigational therapies while contributing to scientific knowledge. But it comes with real obligations (scheduled visits, monitoring, potential placebo assignment) and shouldn't be viewed as a shortcut to getting a drug early.

50 8BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 47 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register